Apr 10 |
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
|
Apr 7 |
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
|
Apr 2 |
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 27 |
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
|
Mar 20 |
Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 12 |
Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
|
Mar 4 |
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
|
Feb 28 |
Q4 2023 Vaxcyte Inc Earnings Call
|
Feb 28 |
Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know
|